Pfizer Beat Sanofi To Isolated DNA Patent, Fed. Circ. Says
The Federal Circuit ruled Tuesday that Pfizer Inc. should be awarded the patent for a DNA sequence that Pfizer and rival pharmaceutical manufacturer Sanofi-Aventis SA had simultaneously researched and both claimed...To view the full article, register now.
Already a subscriber? Click here to view full article